Miriam Jacobs, MD (@mtjacobsmd1) 's Twitter Profile
Miriam Jacobs, MD

@mtjacobsmd1

ID: 1379208261879103488

calendar_today05-04-2021 23:04:17

5 Tweet

45 Followers

107 Following

Fehniger Lab (@labfehniger) 's Twitter Profile Photo

Our recent review of the allo NK / off the shelf / point of care landscape for NK cell therapy! @BerrienElliott Miriam Jacobs, MD #NKcell #CARNK Siteman Cancer Center Test Account @BloodJournal Allogeneic natural killer cell therapy ashpublications.org/blood/article-…

Yucai Wang, MD, PhD (@yucaiwangmd) 's Twitter Profile Photo

Brexu-cel for R/R MCL in standard-of-care practice. Comparable results to ZUMA-2, although follow-up still short. Great collaboration among US Lymphoma CART Consortium. Mayo Clinic Comprehensive Cancer Center MD Anderson Cancer Center Moffitt Cancer Center ascopubs.org/doi/pdf/10.120…

Brexu-cel for R/R MCL in standard-of-care practice. Comparable results to ZUMA-2, although follow-up still short. Great collaboration among US Lymphoma CART Consortium. <a href="/MayoCancerCare/">Mayo Clinic Comprehensive Cancer Center</a> <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> <a href="/MoffittNews/">Moffitt Cancer Center</a> ascopubs.org/doi/pdf/10.120…
Fehniger Lab (@labfehniger) 's Twitter Profile Photo

Updated review on allogeneic NK cell therapy is out in @BloodJournal ! Siteman Cancer Center Test Account @BerrienElliott Miriam Jacobs, MD #NKcell #NKtherapy Allogeneic natural killer cell therapy ashpublications.org/blood/article-…

Fehniger Lab (@labfehniger) 's Twitter Profile Photo

Congrats to Miriam Jacobs, MD and @NKtraineePamela for an outstanding pre-clinical study showing memory-like #NKcells attack HNSCC! Combine with mAbs and CAR! Critical to optimize NK therapy for future clinical trials. Siteman Cancer Center Test Account @WashUOnc pubmed.ncbi.nlm.nih.gov/37556118/